Fiera Capital (Canada)’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $26.2M | Buy |
207,217
+19,797
| +11% | +$2.61M | 0.1% | 153 |
|
|
2026
Q1 | $26.1M | Buy |
+187,420
| New | +$26.2M | 0.09% | 170 |
|
|
2023
Q1 | – | Sell |
-7,460
| Closed | -$640K | – | 508 |
|
|
2022
Q4 | $640K | Sell |
7,460
-28,775
| -79% | -$2.28M | ﹤0.01% | 404 |
|
|
2022
Q3 | $2.23M | Buy |
36,235
+2,500
| +7% | +$158K | 0.01% | 265 |
|
|
2022
Q2 | $2.08M | Buy |
33,735
+19,675
| +140% | +$1.22M | 0.01% | 311 |
|
|
2022
Q1 | $836K | Sell |
14,060
-17,180
| -55% | -$1.1M | ﹤0.01% | 458 |
|
|
2021
Q4 | $2.27M | Sell |
31,240
-10,055
| -24% | -$693K | 0.01% | 301 |
|
|
2021
Q3 | $2.88M | Buy |
41,295
+4,230
| +11% | +$297K | 0.01% | 247 |
|
|
2021
Q2 | $2.55M | Buy |
37,065
+10,540
| +40% | +$704K | 0.01% | 267 |
|
|
2021
Q1 | $1.71M | Sell |
26,525
-975
| -4% | -$62.9K | ﹤0.01% | 320 |
|
|
2020
Q4 | $1.6M | Buy |
+27,500
| New | +$1.66M | ﹤0.01% | 398 |
|
|
2020
Q3 | – | Sell |
-3,351
| Closed | -$258K | – | 627 |
|
|
2020
Q2 | $258K | Sell |
3,351
-35,148
| -91% | -$2.69M | ﹤0.01% | 567 |
|
|
2020
Q1 | $2.88M | Buy |
+38,499
| New | +$2.66M | 0.01% | 266 |
|
|
2019
Q1 | – | Sell |
-9,200
| Closed | -$575K | – | 673 |
|
|
2018
Q4 | $575K | Sell |
9,200
-16,234
| -64% | -$1.13M | ﹤0.01% | 511 |
|
|
2018
Q3 | $1.96M | Buy |
25,434
+240
| +1% | +$18.1K | 0.01% | 422 |
|
|
2018
Q2 | $1.78M | Sell |
25,194
-528
| -2% | -$37.3K | 0.01% | 424 |
|
|
2018
Q1 | $1.94M | Sell |
25,722
-1,222
| -5% | -$97.1K | 0.01% | 397 |
|
|
2017
Q4 | $1.93M | Sell |
26,944
-3,969
| -13% | -$301K | 0.01% | 387 |
|
|
2017
Q3 | $2.5M | Sell |
30,913
-15,862
| -34% | -$1.21M | 0.01% | 358 |
|
|
2017
Q2 | $3.31M | Sell |
46,775
-14,105
| -23% | -$939K | 0.02% | 343 |
|
|
2017
Q1 | $4.13M | Sell |
60,880
-27,368
| -31% | -$1.92M | 0.02% | 317 |
|
|
2016
Q4 | $6.32M | Sell |
88,248
-51,694
| -37% | -$3.84M | 0.04% | 286 |
|
|
2016
Q3 | $11.1M | Sell |
139,942
-272,470
| -66% | -$22.1M | 0.06% | 234 |
|
|
2016
Q2 | $34.4M | Buy |
412,412
+47,606
| +13% | +$4.22M | 0.19% | 134 |
|
|
2016
Q1 | $33.5M | Sell |
364,806
-72,984
| -17% | -$6.58M | 0.25% | 82 |
|
|
2015
Q4 | $44.3M | Sell |
437,790
-12,965
| -3% | -$1.35M | 0.34% | 70 |
|
|
2015
Q3 | $44.3M | Sell |
450,755
-30,832
| -6% | -$3.42M | 0.37% | 72 |
|
|
2015
Q2 | $56.4K | Buy |
481,587
+46,430
| +11% | +$5.07M | 0.35% | 66 |
|
|
2015
Q1 | $42.7M | Sell |
435,157
-40,762
| -9% | -$4.14M | 0.32% | 80 |
|
|
2014
Q4 | $44.9M | Sell |
475,919
-37,284
| -7% | -$3.86M | 0.33% | 75 |
|
|
2014
Q3 | $54.6M | Sell |
513,203
-9,986
| -2% | -$978K | 0.41% | 66 |
|
|
2014
Q2 | $43.4M | Sell |
523,189
-30,127
| -5% | -$2.35M | 0.22% | 97 |
|
|
2014
Q1 | $39.2M | Buy |
553,316
+127,548
| +30% | +$10M | 0.3% | 82 |
|
|
2013
Q4 | $32M | Buy |
425,768
+420,168
| +7,503% | +$29.3M | 0.26% | 96 |
|
|
2013
Q3 | $352K | Sell |
5,600
-400
| -7% | -$23.9K | ﹤0.01% | 330 |
|
|
2013
Q2 | $308K | Buy |
+6,000
| New | +$313K | ﹤0.01% | 338 |
|
Other funds holding GILD
Fiera Capital (Canada)'s GILD Position: Q2 2026 in Review
Fiera Capital (Canada) increased its Gilead Sciences (GILD) stake by 11% in Q2 2026, buying an estimated $2.61M and bringing the position to 207,217 shares worth $26.2M. The position accounts for 0.1% of the portfolio, ranked #153.
Fiera Capital (Canada) first reported a position in GILD in Q2 2013 and has held it in 36 quarters since. The position peaked at $54.6M in Q3 2014. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Fiera Capital (Canada) held 207,217 shares of Gilead Sciences worth $26.2M as of Q2 2026.
- Fiera Capital (Canada) bought 19,797 Gilead Sciences shares in Q2 2026, an estimated $2.61M.
- Gilead Sciences made up 0.1% of Fiera Capital (Canada)'s portfolio in Q2 2026, its #153 holding.
- Fiera Capital (Canada) first reported a position in Gilead Sciences in Q2 2013 and has held it in 36 quarters since.
- Fiera Capital (Canada)'s Gilead Sciences position peaked at $54.6M in Q3 2014.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Fiera Capital (Canada)'s 13F filing for Q2 2026, filed 7 Aug 2026.